Clinical trial
Heart Rate Response to Regadenoson and Sudden Cardiac Death
NCT01842035 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Heart Rate Response to Regadenoson and Sudden Cardiac Death
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- July 31, 2022
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
left ventricular systolic dysfunction, sudden cardiac death